Staar Surgical Co (FRA:SR3) Cyclically Adjusted FCF per Share: €0.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SR3 Staar Surgical Co FRA:SR3
80 GF Score
Price €21.19
GF Value €29.13
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co Cyclically Adjusted FCF per Share?

Staar Surgical Co FRA:SR3 -1.53% 80 Cyclically Adjusted FCF per Share is €0.07 as of Mar. 2026. GuruFocus rates FRA:SR3 with a GF Score™ of 80/100 and a GF Value™ of €29.13 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Staar Surgical Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.376. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Staar Surgical Co's average Cyclically Adjusted FCF Growth Rate was -50.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -13.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Staar Surgical Co was 78.30% per year. The lowest was -67.10% per year. And the median was 7.40% per year.

As of today (2026-07-27), Staar Surgical Co's current stock price is €21.19. Staar Surgical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.07. Staar Surgical Co's Cyclically Adjusted Price-to-FCF of today is 302.71.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Staar Surgical Co was 5904.00. The lowest was 90.29. And the median was 397.72.


Staar Surgical Co  (FRA:SR3) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Staar Surgical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=21.19/0.07
=302.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Staar Surgical Co was 5904.00. The lowest was 90.29. And the median was 397.72.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Staar Surgical Co Cyclically Adjusted FCF per Share Related Terms


Staar Surgical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co Cyclically Adjusted FCF per Share Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.16 0.15 0.16 0.09

Staar Surgical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.09 0.09 0.09 0.07

FRA:SR3 vs KMTS, AZTA, BLFS: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Cyclically Adjusted Price-to-FCF falls into.


FRA:SR3
80GF Score
Staar Surgical Co FRA:SR3
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Staar Surgical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.376/330.2130*330.2130
=-0.376

Current CPI (Mar. 2026) = 330.2130.

Staar Surgical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.034 241.018 0.047
201609 0.015 241.428 0.021
201612 -0.009 241.432 -0.012
201703 -0.022 243.801 -0.030
201706 -0.023 244.955 -0.031
201709 0.055 246.819 0.074
201712 0.021 246.524 0.028
201803 0.029 249.554 0.038
201806 -0.010 251.989 -0.013
201809 0.143 252.439 0.187
201812 0.034 251.233 0.045
201903 -0.028 254.202 -0.036
201906 0.020 256.143 0.026
201909 0.179 256.759 0.230
201912 0.130 256.974 0.167
202003 -0.208 258.115 -0.266
202006 -0.040 257.797 -0.051
202009 0.133 260.280 0.169
202012 0.292 260.474 0.370
202103 0.079 264.877 0.098
202106 0.048 271.696 0.058
202109 0.326 274.310 0.392
202112 0.068 278.802 0.081
202203 -0.132 287.504 -0.152
202206 0.153 296.311 0.171
202209 0.364 296.808 0.405
202212 -0.020 296.797 -0.022
202303 -0.151 301.836 -0.165
202306 -0.174 305.109 -0.188
202309 -0.288 307.789 -0.309
202312 0.538 306.746 0.579
202403 0.310 312.332 0.328
202406 -0.311 314.175 -0.327
202409 -0.044 315.301 -0.046
202412 -0.099 315.605 -0.104
202503 -0.135 319.799 -0.139
202506 -0.508 322.561 -0.520
202509 0.030 324.800 0.030
202512 -0.096 324.054 -0.098
202603 -0.376 330.213 -0.376

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.07 mean?
Staar Surgical Co (FRA:SR3) has a Cyclically Adjusted FCF per Share of €0.07 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Staar Surgical Co and its competitors.
Is Staar Surgical Co's Cyclically Adjusted FCF per Share too high?
Staar Surgical Co's current Cyclically Adjusted FCF per Share is €0.07. Overall, Staar Surgical Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Cyclically Adjusted FCF per Share compare to KMTS and AZTA?
Staar Surgical Co's Cyclically Adjusted FCF per Share of €0.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current Cyclically Adjusted FCF per Share is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (FRA:SR3) is currently considered Modestly Undervalued. The stock's GF Value™ is €29.13, compared to a current price of €21.19 — trading 27.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.07. Staar Surgical Co's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Staar Surgical Co (FRA:SR3), the current Cyclically Adjusted FCF per Share is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (FRA:SR3) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of €21.19 is trading 27.3% below its estimated GF Value™ of €29.13. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for FRA:SR3:

  • Cyclically Adjusted FCF per Share: €0.07
  • GF Value™: €29.13 vs. price of €21.19 (27.3% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the FRA:SR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staar Surgical Co Business Description

Other Exchanges STAA:USA
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
80GF Score

Get the complete analysis for FRA:SR3

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.19
Price
€29.13
GF Value